Filing Details
- Accession Number:
- 0001567619-18-001756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-23 18:03:56
- Reporting Period:
- 2018-08-21
- Accepted Time:
- 2018-08-23 18:03:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1526223 | Jacqueline Studer | One Idexx Drive Westbrook ME 04092 | Cvp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-21 | 9,400 | $67.85 | 17,034 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-21 | 2,219 | $141.60 | 19,253 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-21 | 5,549 | $243.36 | 13,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-21 | 2,806 | $244.15 | 10,898 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-21 | 3,264 | $245.06 | 7,634 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2018-08-21 | 9,400 | $0.00 | 9,400 | $67.85 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2018-08-21 | 2,219 | $0.00 | 2,219 | $141.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,627 | 2026-02-13 | No | 4 | M | Direct | |
| 8,167 | 2027-02-13 | No | 4 | S | Direct |
Footnotes
- Represents the weighted average sales price of the shares sold ranging from a low of $243.00 to a high of $243.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $244.00 to a high of $244.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $245.00 to a high of $245.13 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Grant of option to buy 22,027 shares of IDEXX Laboratories, Inc. common stock that vests and is exercisable in five equal annual installments beginning on February 14, 2017.
- Grant of option to buy 10,386 shares of IDEXX Laboratories, Inc. common stock that vests and is exercisable in five equal annual installments beginning on February 14, 2018.
- Not applicable.
Billionaire Hedge Funds
